Physician profile
Luke Thomas Small
NPI 1811315161
$703.36
in general payments reported to CMS, 2019-2025
8 companies · $85.05 in 2025
The $85.05 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $190 · 2022: $31.20 · 2023: $122 · 2024: $21.36 · 2025: $85.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133 · Education: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.91 |
| Education | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $217.38 | 2019-2022 | |
| Smith+Nephew, INC. | $210.82 | 2019 | |
| Abbvie INC. | $95.00 | 2023 | Infed |
| Genzyme Corporation | $87.17 | 2024-2025 | |
| Inspire Medical Systems, INC. | $45.74 | 2023-2025 | Inspire |
| Intersect Ent, INC. | $19.47 | 2019 | |
| Merck Sharp & Dohme LLC | $15.96 | 2020 | |
| Medtronic USA, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.